Effect of chromogranin A (pancreastatin) fragment on invasion of prostate cancer cells

Cancer Lett. 1999 Dec 1;147(1-2):207-13. doi: 10.1016/s0304-3835(99)00309-2.

Abstract

We investigated the effect of chromogranin A (pancreastatin) fragment on the invasion of PC-3, DU-145 and LNCaP prostate cancer cells through a reconstituted basement membrane (Matrigel) using a Transwell cell culture chamber assay. Chromogranin A fragment increased the invasive capacity of both PC-3 and DU- 145 cells, whereas it had no significant effect of LNCaP cells. Chromogranin A fragment also increased the haptotactic migration of both PC-3 and DU-145 cells to fibronectin. Furthermore chromogranin A fragment increased the fibrinolytic activities of urokinase-type plasminogen activator (u-PA) in fibrin zymograms of both PC-3 and DU-145 cells and the expression of u-PA mRNA of PC-3 cells. However, the growth of these tumor cells was not affected by chromogranin A fragment at any concentrations used in this study. These results indicate that chromogranin A fragment increased the invasive potential of both PC-3 and DU-145 cells probably through enhancement of cell motility and the production of u-PA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Division / drug effects
  • Cell Movement / drug effects
  • Chemotaxis / drug effects
  • Chromogranin A
  • Chromogranins / pharmacology*
  • Collagen / metabolism
  • Diffusion Chambers, Culture
  • Drug Combinations
  • Fibrinolysis / drug effects
  • Humans
  • Laminin / metabolism
  • Male
  • Neoplasm Invasiveness
  • Peptide Fragments / pharmacology*
  • Prostatic Neoplasms / pathology*
  • Prostatic Neoplasms / physiopathology*
  • Proteoglycans / metabolism
  • RNA, Messenger / biosynthesis
  • Reverse Transcriptase Polymerase Chain Reaction
  • Tumor Cells, Cultured
  • Urokinase-Type Plasminogen Activator / biosynthesis
  • Urokinase-Type Plasminogen Activator / genetics

Substances

  • CHGA protein, human
  • Chromogranin A
  • Chromogranins
  • Drug Combinations
  • Laminin
  • Peptide Fragments
  • Proteoglycans
  • RNA, Messenger
  • matrigel
  • Collagen
  • Urokinase-Type Plasminogen Activator